Europe Histopathology Services Market by Type of Examination - Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4580520
  • Report
  • Region: Europe
  • 128 pages
  • Allied Analytics LLP
1 of 4
The Europe histopathology services market was valued at $5,583 million in 2016, and is expected to reach $8,766 million by 2023, growing at a CAGR of 6.6% from 2017 to 2023.

Histopathology is a branch of pathology, which deals with the microscopic analysis of biological tissues to detect the presence of diseased cells/tissues. It involves the study of infinitesimal changes/aberrations in tissues that are caused due to some diseases. Histopathology tests are conducted in histopathology laboratories, wherein a pathologist studies changes or abnormalities in tissues caused by a disease.

The growth of the Europe histopathology services market is driven by increase in prevalence of cancer & other chronic disorders, rapid surge in geriatric population in Europe, and rise in public awareness for disease screening. However, limitations of histopathology and dearth in number pathologists & medical laboratory scientists in the UK restrain the growth of the market. Conversely, increase in demand for personalized medicine is expected to provide potential opportunities for market expansion during the forecast period.

The report segments the Europe histopathology services market based on type of examination and country. Depending on type of examination, the market is fragmented into surgical specimen, gastrointestinal biopsy, breast biopsy, lung biopsy, biopsy of gynecological cancers, renal biopsy, pancreatic biopsy, skin tissue biopsy, liver biopsy, nerve biopsy, testicular biopsy, and others. On the basis of country, it is analyzed across Germany, France, the UK, Spain, and rest of Europe.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Analysis by type of examination helps to understand the various types of histopathological tests and tissues used for a histopathological examination.
Comprehensive analysis of major countries in Europe is provided to determine the prevailing opportunities.
Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Type of Examination

Surgical Specimen
Gastrointestinal Biopsy
Breast Biopsy
Lung Biopsy
Biopsy of Gynecological Cancers
Renal Biopsy
Pancreatic Biopsy
Skin Tissue Biopsy
Liver Biopsy
Nerve Biopsy
Testicular Biopsy
Others

By Country

Germany
France
UK
Italy
Spain
Rest of Europe

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Acculabs Diagnostics UK Ltd.
Cellular Pathology Services Limited
Great Ormond Street Hospital (GOSH) Laboratory
HCA Laboratories UK
Laboratoire Cerba
Sonic Healthcare Limited
Spire Healthcare Group Plc.
Targos Molecular Pathology GmbH
TPL Path Labs
Unilabs Group Services
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top player positioning
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Increase in prevalence of cancer and other chronic disorders
3.3.1.2. Rapid growth in geriatric population
3.3.1.3. Rise in public awareness for disease screening
3.3.2. Restraints
3.3.2.1. Limitations of histopathology
3.3.2.2. Shortage of pathologists in the UK
3.3.3. Opportunity
3.3.3.1. Increase in demand for personalized medicine

CHAPTER 4: EUROPE HISTOPATHOLOGY SERVICES MARKET, BY TYPE OF EXAMINATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Surgical specimen
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Gastrointestinal biopsy
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Breast biopsy
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.5. Lung biopsy
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.6. Biopsy for gynecological cancers
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast
4.7. Renal biopsy
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast
4.8. Pancreatic biopsy
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast
4.9. Skin tissue biopsy
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast
4.10. Liver biopsy
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast
4.11. Nerve biopsy
4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast
4.12. Testicular biopsy
4.12.1. Key market trends, growth factors, and opportunities
4.12.2. Market size and forecast
4.13. Others
4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast

CHAPTER 5: EUROPE HISTOPATHOLOGY SERVICES MARKET, BY COUNTRY
5.1. Overview
5.1.1. Market size and forecast
5.2. Germany
5.2.1. Market size and forecast
5.3. France
5.3.1. Market size and forecast
5.4. UK
5.4.1. Market size and forecast
5.5. Italy
5.5.1. Market size and forecast
5.6. Spain
5.6.1. Market size and forecast
5.7. Rest of Europe
5.7.1. Market size and forecast

CHAPTER 6: COMPANY PROFILES
6.1. Acculabs Diagnostics UK Ltd.
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segment
6.2. Cellular Pathology Services Limited
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.3. Great Ormond Street Hospital (GOSH) Laboratory
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.4. HCA Laboratories UK
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segment
6.5. Laboratoire Cerba
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.6. Sonic Healthcare Limited
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Business performance
6.7. Spire Healthcare Group Plc
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Business performance
6.7.4. Key strategic moves and developments
6.8. Targos Molecular Pathology GmbH
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.9. TPL Path Labs
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.10. Unilabs Group Services
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Europe Histopathology Services Market by Type of Examination Opportunity Analysis and Industry Forecast, 2017-2023," the Europe histopathology services market was valued at $5,583 million in 2016, and is expected to reach $8,766 million by 2023, growing at a CAGR of 6.6% from 2017 to 2023.

Histopathology is a branch of pathology, which deals with the study of changes in tissue occurring due to a disease. In this procedure, suspected tissues (for a disease) are removed from a patient's body and examined in a laboratory to study manifestations of the disease.

Increase in prevalence of cancer & other chronic disorders, rapid growth in geriatric population in Europe, and rise in public awareness towards disease screening drive the growth of the Europe histopathology services market. However, limitations of histopathology, as the technique is subjected to human error during analysis and preparation of tissue slides, and dearth of pathologists & medical laboratory scientists in the UK are expected to impede the market growth. On the contrary, increase in demand for personalized medicine is expected to offer ample opportunities for market expansion during the forecast period.

The surgical specimen segment accounted for nearly half of the market share in 2016, and is expected to maintain its dominant position during the analysis period, owing to increase in number of surgical procedures across Europe.

Key Findings of the Europe Histopathology Services Market

The liver biopsy segment is expected to grow at a CAGR of 9.9% from 2017 to 2023.
UK is expected to grow at the highest CAGR of 7.4%.
Germany held a major share of 19.6% in 2016 in the European market, and is expected to retain its position throughout the forecast period.
Gastrointestinal biopsy segment held a share of 11.6% in 2016.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll